Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00150657
Title Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. John Providence Health System
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab + Carboplatin + Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.